1.5 Abstract in rivista

1.5 Abstract in rivista: [2371] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.221 a 1.240 di 2.371

Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with Rituximab as frontline therapy for high-risk follicular lymphoma (FL) patients: An interim analysis.

2002 Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Liberati, Anna Marina; Et, All

Phase II study with Fludarabine and Cyclophosphamide plus Rituximab (FC plus R) in relapsed follicular lymphoma patients

2002 Sacchi, S; Tucci, A; Merli, F; Orsucci, L; Cervetti, G; Occhini, U; Liberati, Anna Marina

Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with rituximab in poor-risk follicular lymphoma: early evaluation on treatment feasibility and response rate

2003 Ladetto, M; Ricca, I; Benedetti, F; Liberati, Anna Marina

Acute myeloid leukemia in the elderly, intensive or maintenance therapy? Our experience in patients over 65 years.

2005 Mettivier, V; Pezzullo, L; Rocco, S; Finizio, O; Bene, L.; De Rosa, C; Nunziata, Gr; Liberati, Anna Marina

Anagrelide treatment and cardiovascular evaluation in 130 patients with essential thrombocythemia (ET): Preliminary report of the Registro Italiano Trombocitemia (RIT).

2005 Gugliotta, L; Tieghi, A; Bulgarelli, S; Tortorella, C; Ciancia, R; Scalzulli, Pr; Cacciola, E; Cacciola, R; Rossi, D; Usala, E; Crugnola, M; Candoni, A.; Giordano, M; Andriani, A; Santoro, C; Vimercati, R; Liberati, Anna Marina; Et, All

Comparative trial of BBR 2778 (pixantrone) plus rituximab vs single agent rituximab in the treatment of relapsed/refractory indolent non-Hodgkin's lymphoma (NHL).

2006 Santoro, A; Voglova, J; Gabrail, N; Ciuleanu, T; Liberati, Anna Marina

Rituximab (R) in combination with fludarabine (F) and cyclophosphamide (C) in relapsed follicular lymphoma (FL) patients (pts). Final results of FC plus R phase II trial by the GISL.

2006 Sacchi, S; Pozzi, S; Marcheselli, R; Luminari, S; Federico, M; Tucci, A; Merli, F; Orsucci, L.; Cervetti, G; Occhini, U; Liberati, Anna Marina

Preoperative MUCP and VLPP failed to predict outcome in patients who underwent transobturator mid-urethral slings

2008 Costantini, Elisabetta; Lazzeri, Massimo; Giannantoni, Antonella; Bini, Vittorio; Mearini, Luigi; Zucchi, Alessandro; Porena, Massimo

The role of sulphate, in hyperomocysteinemia in patients with Helicobacter pylori.

2001 Capodicasa, Enrico; Pelli, Ma; De Medio, Ge; Brunetti, M:

Rottura spontanea del fegato in corso di sindrome di Budd-Chiari da Lupus anticoagulant

2001 Capodicasa, Enrico; Acciarini, Ae; Gerli, Roberto; DEL FAVERO, Albano

Valutazione della capacità sierica scavenger verso il rdicale idrossilico in pazienti emodializzati.

2012 Capodicasa, Enrico; Bottilglieri, L.; Orsi, E.; Standoli, M. L.; De Santis, P.; Scaccetti, A.; Biondi, Roberto

A pilot study with all-trans retinoic acid plus tamoxifen and vitamin E in patients with hepatocellular carcinoma (HCC): a four years follow-up

2002 Clerici, C; Fiorucci, Stefano; Castellani, D; Russo, G; Gentili, G; Morelli, Olivia; Baldoni, Monia

NCX 1000, an NO-derivative of ursodeoxycholic acid protects against Th1-mediated liver damage in mice.

2000 Fiorucci, Stefano; Santucci, L; Mencarelli, A; Morelli, Olivia; Del Soldato, P; Morelli, Antonio

Long Term Follow-up Analysis of HD9601 Trial Comparing ABVD Vs Stanford V Vs MOPPABVCAD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma. A Study from the Intergruppo Italiano Linforni (IIL).

2008 Chisesi, T; Bellei, M; Luminari, S; Marcheselli, L; Levis, A; Vitolo, U; Stelitano, C; Pavone, V; Merli, F; Liberati, Anna Marina

ABVD versus VEPEMB in elderly Hodgkin's lymphoma patients

2007 Levis, A; Merli, F.; Tamiazzo, S; Arcari, A; Bellei, M; Brugiatelli, M; Federico, M; Liberati, Anna Marina; Et, All

Sequential Approach with Bortezomib as Induction Before Autologous Transplantation, Followed by Lenalidomide as Consolidation-Maintenance in Untreated Multiple Myeloma Patients

2009 Gay, F.; Falco, P; Crippa, C; Liberati, Anna Marina; Et, All

A prospective randomized controlled trial of oral melphalan, prednisone, thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients

2006 Palumbo, A; Aitoro, G; Bringhen, S.; Caravita, T; Callea, V; Zambello, R; Pregno, P; Carubelli, A; Baraldi, A; Cellini, C; Dore, F; Piro, E; Ambrosini, Mt; Musto, P; Liberati, Anna Marina; Boccadoro, M.

Mobilising chemotherapy affects the recovery of clonogenic peripheral blood stem cells

2006 Schippa, M; Falchi, L.; Rauco, A; Desantis, G; Merluzzi, M; Ferrara, P; Lugini, A; Liberati, Anna Marina

Impact of early consolidation with bortezomib, thalidomide and dexamethasone on molecularly-detectable disease in MM patients in CR or VGPR following autologous transplantation: Uncommon achievement of molecular remission despite evidence of tumor load reduction by real time PCR.

2006 Ladetto, M; Astolfi, M; Santo, L; Avonto, I; Cavallo, F; Pagliano, G; Pregno, P; Grasso, M; Liberati, Anna Marina

Rituximab-supplemented high-dose sequential chemotherapy (R-HDS) has better EFS and PFS than R-CHOP in poor risk follicular lymphoma (FL) at diagnosis: A multicenter randomized GITMO/IIL trial.

2006 Ladetto, M; Benedetti, F; Vitolo, U; Patti, C; Rambaldi, A; Liberati, Anna Marina; Et, All

Titolo	Data di pubblicazione	Autore(i)
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with Rituximab as frontline therapy for high-risk follicular lymphoma (FL) patients: An interim analysis.	2002	Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Liberati, Anna Marina; Et, All
Phase II study with Fludarabine and Cyclophosphamide plus Rituximab (FC plus R) in relapsed follicular lymphoma patients	2002	Sacchi, S; Tucci, A; Merli, F; Orsucci, L; Cervetti, G; Occhini, U; Liberati, Anna Marina
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with rituximab in poor-risk follicular lymphoma: early evaluation on treatment feasibility and response rate	2003	Ladetto, M; Ricca, I; Benedetti, F; Liberati, Anna Marina
Acute myeloid leukemia in the elderly, intensive or maintenance therapy? Our experience in patients over 65 years.	2005	Mettivier, V; Pezzullo, L; Rocco, S; Finizio, O; Bene, L.; De Rosa, C; Nunziata, Gr; Liberati, Anna Marina
Anagrelide treatment and cardiovascular evaluation in 130 patients with essential thrombocythemia (ET): Preliminary report of the Registro Italiano Trombocitemia (RIT).	2005	Gugliotta, L; Tieghi, A; Bulgarelli, S; Tortorella, C; Ciancia, R; Scalzulli, Pr; Cacciola, E; Cacciola, R; Rossi, D; Usala, E; Crugnola, M; Candoni, A.; Giordano, M; Andriani, A; Santoro, C; Vimercati, R; Liberati, Anna Marina; Et, All
Comparative trial of BBR 2778 (pixantrone) plus rituximab vs single agent rituximab in the treatment of relapsed/refractory indolent non-Hodgkin's lymphoma (NHL).	2006	Santoro, A; Voglova, J; Gabrail, N; Ciuleanu, T; Liberati, Anna Marina
Rituximab (R) in combination with fludarabine (F) and cyclophosphamide (C) in relapsed follicular lymphoma (FL) patients (pts). Final results of FC plus R phase II trial by the GISL.	2006	Sacchi, S; Pozzi, S; Marcheselli, R; Luminari, S; Federico, M; Tucci, A; Merli, F; Orsucci, L.; Cervetti, G; Occhini, U; Liberati, Anna Marina
Preoperative MUCP and VLPP failed to predict outcome in patients who underwent transobturator mid-urethral slings	2008	Costantini, Elisabetta; Lazzeri, Massimo; Giannantoni, Antonella; Bini, Vittorio; Mearini, Luigi; Zucchi, Alessandro; Porena, Massimo
The role of sulphate, in hyperomocysteinemia in patients with Helicobacter pylori.	2001	Capodicasa, Enrico; Pelli, Ma; De Medio, Ge; Brunetti, M:
Rottura spontanea del fegato in corso di sindrome di Budd-Chiari da Lupus anticoagulant	2001	Capodicasa, Enrico; Acciarini, Ae; Gerli, Roberto; DEL FAVERO, Albano
Valutazione della capacità sierica scavenger verso il rdicale idrossilico in pazienti emodializzati.	2012	Capodicasa, Enrico; Bottilglieri, L.; Orsi, E.; Standoli, M. L.; De Santis, P.; Scaccetti, A.; Biondi, Roberto
A pilot study with all-trans retinoic acid plus tamoxifen and vitamin E in patients with hepatocellular carcinoma (HCC): a four years follow-up	2002	Clerici, C; Fiorucci, Stefano; Castellani, D; Russo, G; Gentili, G; Morelli, Olivia; Baldoni, Monia
NCX 1000, an NO-derivative of ursodeoxycholic acid protects against Th1-mediated liver damage in mice.	2000	Fiorucci, Stefano; Santucci, L; Mencarelli, A; Morelli, Olivia; Del Soldato, P; Morelli, Antonio
Long Term Follow-up Analysis of HD9601 Trial Comparing ABVD Vs Stanford V Vs MOPPABVCAD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma. A Study from the Intergruppo Italiano Linforni (IIL).	2008	Chisesi, T; Bellei, M; Luminari, S; Marcheselli, L; Levis, A; Vitolo, U; Stelitano, C; Pavone, V; Merli, F; Liberati, Anna Marina
ABVD versus VEPEMB in elderly Hodgkin's lymphoma patients	2007	Levis, A; Merli, F.; Tamiazzo, S; Arcari, A; Bellei, M; Brugiatelli, M; Federico, M; Liberati, Anna Marina; Et, All
Sequential Approach with Bortezomib as Induction Before Autologous Transplantation, Followed by Lenalidomide as Consolidation-Maintenance in Untreated Multiple Myeloma Patients	2009	Gay, F.; Falco, P; Crippa, C; Liberati, Anna Marina; Et, All
A prospective randomized controlled trial of oral melphalan, prednisone, thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients	2006	Palumbo, A; Aitoro, G; Bringhen, S.; Caravita, T; Callea, V; Zambello, R; Pregno, P; Carubelli, A; Baraldi, A; Cellini, C; Dore, F; Piro, E; Ambrosini, Mt; Musto, P; Liberati, Anna Marina; Boccadoro, M.
Mobilising chemotherapy affects the recovery of clonogenic peripheral blood stem cells	2006	Schippa, M; Falchi, L.; Rauco, A; Desantis, G; Merluzzi, M; Ferrara, P; Lugini, A; Liberati, Anna Marina
Impact of early consolidation with bortezomib, thalidomide and dexamethasone on molecularly-detectable disease in MM patients in CR or VGPR following autologous transplantation: Uncommon achievement of molecular remission despite evidence of tumor load reduction by real time PCR.	2006	Ladetto, M; Astolfi, M; Santo, L; Avonto, I; Cavallo, F; Pagliano, G; Pregno, P; Grasso, M; Liberati, Anna Marina
Rituximab-supplemented high-dose sequential chemotherapy (R-HDS) has better EFS and PFS than R-CHOP in poor risk follicular lymphoma (FL) at diagnosis: A multicenter randomized GITMO/IIL trial.	2006	Ladetto, M; Benedetti, F; Vitolo, U; Patti, C; Rambaldi, A; Liberati, Anna Marina; Et, All

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.221 a 1.240 di 2.371

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2371

IRIS - Res&Arch Institutional Research Information System - Research & Archive